SOD1 and type 2 diabetes mellitus: Following the introduction of betulin at a dose of 20 mg/kg to diabetic rats (T2D + BE20), the glutathione levels in blood plasma increased substantially; however, no significant differences were observed in the levels of MDA, SOD, or CAT when compared to those in the untreated group of rats with T2D.